Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases

Cellular and Molecular Life Sciences

Volumn 55, Issue 12, 1999, Pages 1610-1625

  Adorini, L ^a  

^a ROCHE MILANO RICERCHE   (Italy)

Author keywords

Autoimmune diseases; IL 12 deficient mice; Insulin dependent diabetes mellitus; Interleukin 12; NOD mice; Th1; Th2

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; RECEPTOR SUBUNIT;

ANTIGEN PRESENTING CELL; ASTROCYTE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MYASTHENIA GRAVIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; INTERLEUKIN-12; TH1 CELLS;

EID: 0032855783     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050400     Document Type: Review

References (169)

1. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A. and Coffmann R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profile of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357
2. Del Prete G., De Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P. et al. (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88: 346-350
3. Gately M. K., Renzetti L. M., Magram J., Stern A. S., Adorini L., Gubler U. et al. (1998) The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16: 495-512
4. Paul W. E. and Seder R. A. (1994) Lymphocyte responses and cytokines. Cell 76: 241-251
5. O'Garra A. (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283
6. 4 T cells. J. Exp. Med. 182: 1591-1596
7. 4 helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182: 1579-1584
8. Chen Y., Inobe J.-I., Marks R., Gonnella P., Kuchroo V. K. and Weiner H. L. (1995) Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376: 177-180
9. 2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183: 485-497
10. Nicholson L. B., Greer J. M., Sobel R. A., Lees M. B. and Kuchroo V. K. (1995) An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3: 397-405
11. Hsieh C., Macatonia S. E., O'Garra A. and Murphy K. M. (1995) T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181: 713-731
12. Szabo S. J., Jacobson A. G., Gubler U. and Murphy K. M. (1995) Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2: 665-675
13. Gorham J. D., Guler M. L., Steen R. G., Mackey A. J., Daly M. J., Frederick K. et al. (1996) Genetic mapping of a murine locus controlling development of T helper I/T helper 2 type responses. Proc. Natl. Acad. Sci. USA 93: 12467-12471
14. 4 T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549
15. Reiner S. L. and Locksley R. M. (1995) The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151-177
16. Romagnani S. (1994) Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12: 227-257
17. Openshaw P., Murphy E. E., Hosken N. A., Maino V., Davis K., Murphy K. et al (1995) Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182: 1357-1367
18. Mosmann T. R. and Sad S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17: 138-146
19. Pernis A., Gupta S., Gollob K. J., Garfein E., Coffman R. L., Schindler C. et al. (1995) Lack of interferon γ receptor β chain and the prevention of interferon γ signaling in Th1 cells. Science 269: 245-247
20. Bach E. A., Szubo S., Dighe A. S., Ashkenazi A., Aguet M., Murphy K. M. et al. (1995) Ligand-induced autoregulation of IFN-γ receptor β chain expression in T helper cell subsets. Science 270: 1215-1218
21. Rogge L., Barberis-Maino L., Biffi M., Passim N., Presky D. H., Gubler U. et al. (1997) Selective expression of an interleukin-12 receptor component by human T helper I cells. J. Exp. Med. 185: 825-831
22. Szabo S. J., Dighe A. S., Gubler U. and Murphy K. M. (1997) Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper I (Th1) and Th2 cells. J. Exp. Med. 185: 817-824
23. Rogge L., D'Ambrosio D., Biffi M., Penna G., Minetti L., Presky D. et al. (1998) The role of STAT-4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161: 6567-6574
24. Galbiati F., Rogge L., Guéry J.-C., Smiroldo S. and Adorini L. (1998) Regulation of the interleukin (IL)-12 receptor β2 subunit by soluble antigen and IL-12 in vivo. Eur. J. Immunol. 28: 209-220
25. Agarwal S. and Rao A. (1998) Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9: 765-775
26. Manetti R., Parronchi P., Giudizi M. G., Piccinni M.-P., Maggi E., Trinchieri G. et al. (1993) Natural killer cell stimulatory factor (interleukin 12, IL-12) induces T helper type I (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177: 1199-1204
27. Afonso L. C. C., Scharton T. M., Vieira L. Q., Wysocka M., Trinchieri G. and Scott P. (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235-237
28. Kiniwa M., Gately M., Gubler U., Chizzonite R., Fargeas C. and Delespesse G. (1992) Recombinant interleukin-12 suppresses the synthesis of IgE by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90: 262-266
29. 4 T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24: 793-798
30. Gajewski T. F. and Fitch F. W. (1988) Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140: 4245-4253
31. Moore K., O'Garra A., de Waal Malefyt R., Vieira P. and Mosmann T. R. (1993) Interleukin-10. Annu. Rev. Immunol. 11: 165-190
32. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M. and Trinchieri G. (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041-1048
33. De Waal Malefyt R., Figdor C. G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J. et al. (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151: 6370-6381
34. Wang Z. E., Zheng S., Corry D. B., Dalton D. K., Seder R. A., Reiner S. L. et al. (1994) Interferon gamma-independent effects of interleukin-12 administered during acute or established infection due 10 Leishmania major. Proc. Natl. Acad. Sci. USA 91: 12932-12936
35. 4 T cells. Eur. J. Immunol. 24: 343-347
36. Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L. et al. (1991) Cloning of cDNA for natural killer stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Immunol. 146: 3074-3081
37. Gubler U., Chua A. O., Schoenhaut D. S., Dwyer C. M., McComas W., Motyka R. et al. (1991) Coexpression of two distinct genes is required to generate secreted, bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88: 4143-4147
38. Cassatella M. A., Meda L., Gasperini S., D'Andrea A., Ma X. and Trinchieri G. (1995) Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25: 1-5
39. Trinchieri G. (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type I and cytotoxic lymphocytes. Blood 84: 4008-4027
40. h2 cells. Eur. J. Immunol. 23: 1762-1770
41. 4 T cells to protein antigens in vivo. J. Immunol. 155: 3734-3741
42. Epstein M. M., Di Rosa F., Jankovic D., Sher A. and Matzinger P. (1995) Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182: 915-922
43. 4 T cells. J. Immunol. 154: 4915-4923
44. Crowley M. T., Inaba K. and Steinman R. M. (1990) Dendritic cells arc the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 172: 383-386
45. Guéry J.-C., Sette A., Leighton J., Dragomir A. and Adorini L. (1992) Selective immunosuppression by administration of MHC class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation. J. Exp. Med. 175: 1345-1352
46. Guéry J.-C., Neagu M., Rodriguez-Tarduchy G. and Adorini L. (1993) Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary antibody responses. J. Exp. Med. 177: 1461-1468
47. Guéry J. C., Ria F. and Adorini L. (1996) Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells following administration of protein in adjuvant. J. Exp. Med. 183: 751-757
48. Guéry J. C., Ria F., Galbiati F., Smiroldo S. and Adorini L. (1997) The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells. Int. Immunol. 9: 9-15
49. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S. et al. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845
50. Stern A. S., Podlaski F. J., Hulmes J. D., Pan Y.-C. E., Quinn P. M., Wolitzky A. G. et al. (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87: 6808-6812
51. O'Garra A., Hosken N., Macatonia S., Wenner C. A. and Murphy K. (1995) The role of macrophage- and dendritic cell-derived IL-12 in Th1 phenotype development. Res. Immunol. 146: 466-472
52. Maruo S., Oh-hora M., Ahn H.-J., Wysocka M., Kaneko Y., Yagita H. et al. (1997) B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell APC interactions. J. Immunol. 158: 120-126
53. D'Andrea A., Rengaraju M., Valiante N. M., Chehimi J., Kubin M., Aste M. et al. (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Esp. Med. 176: 1387-1398
54. 4 T cells. J. Immunol. 154: 5071-5079
55. Heufler C., Koch F., Stanzl U., Topar G., Wysoka M., Trinchieri G. et al. (1996) Interleukin-12 is produced by dendritic cells and mediates T helper I development as well as interferon-γ production by T helper I cells. Eur. J. Immunol. 26: 659-668
56. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kaempgen E. et al. (1996) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184: 741-746
57. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A. and Alber G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752
58. Guéry J. C., Ria F., Galbiati F. and Adorini L. (1997) Normal B cells fail to secrete IL-12. Eur. J. Immunol. 27: 1632-1639
59. Rissoan M.-C., Soumelis V., Kadowaki N., Grouard G., Briere F., Waal Malefyt R. de et al. (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 183-186
60. Trembleau S., Penna G., Bosi E., Mortara A., Gately M. K. and Adorini L. (1995) IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181: 817-821
61. Trembleau S., Germann T., Gately M. K. and Adorini L. (1995) The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16: 383-386
62. Ronchese F. and Hausmann B. (1993) B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J. Exp. Med. 177: 679-690
63. Racke M. K., Bonomo A., Scott D. E., Cannella B., Levine A., Raine C. S. et al. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180: 1961-1966
64. Croft M. and Swain S. L. (1995) Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J. Immunol. 154: 4269-4282
65. Stockinger B., Zal T., Zal A. and Gray D. (1996) B cells solicit their own help from T cells. J. Exp. Med. 183: 891-899
66. Day M. J., Tse A. G. D., Puklavec M., Simmonds S. J. and Mason D. W. (1992) Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in nits. J. Exp. Med. 175: 655-659
67. Saoudi A., Simmonds S., Huitinga I. and Mason D. W. (1995) Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of autoantigen-specific T cells. J. Exp. Med. 182: 335-344
68. Eynon E. E. and Parker D. C. (1992) Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175: 131-138
69. Wolf S. D., Dittel B. N., Hardardottir F. and Janeway C. A. (1996) Experimental autoimmune encephalomielitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278
70. 4 T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181: 1081-1089
71. 4 T cell population to the T helper 2 pathway. J. Immunol. 157: 3260-3269
72. Schultze J. L., Michalak S., Lowne J., Wong A., Gilleece M., Gribben J. et al. (1999) Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J. Exp. Med. 189: 1-11
73. Goodman R. E., Nestle F., Naidu Y. M., Green J. M., Thompson C. B., Nickoloff B. J. et al. (1994) Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J. Immunol. 152: 5189-5198
74. Inaba K., Metlay J., Crowley M. T. and Steinman R. M. (1990) Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172: 631-640
75. Ronchese R., Hausmann G. and Le Gros B. (1994) Interferon-γ- and interleukin-4-producing T cells can be primed on dendritic cells in vivo and do not require the presence of B cells. Eur. J. Immunol. 24: 1148-1154
76. Steinman R. M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296
77. Hino A. and Nariuchi H. (1996) Negative feedback mechanism suppresses IL-12 production by antigen-presenting cells interacting with T helper 2 cells. Eur. J. Immunol. 26: 623-628
78. Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L. et al (1997) Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185: 317-328
79. Ria F., Penna G. and Adorini L. (1998) Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells. Eur. J. Immunol 28: 2003-2016
80. DeKruyff R. H., Gieni R. S. and Umetsu D. T. (1997) Antigen-driven but not lipopolysaccharide-driven IL-12 production by macrophages requires triggering of CD40. J. Immunol. 158: 359-366
81. Murphy E. E., Terres G., Macatonia S. E., Hsieh C. -S., Mattson J., Lanier L. et al. (1994) B7 and interleukin 12 cooperate for proliferation and interferon γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180: 223-231
82. Neurath M. F., Fuss L. Kelsall B. L., Stueber E. and Strober W. (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281-1290
83. Leonard J. P., Waldburger K. E. and Goldman S. J. (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 181: 381-386
84. Becher B., Dodelet V., Fedorowicz V. and Antel J. P. (1996) Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invert. 98: 1539-1543
85. Aloisi F., Penna G., Cerase J., Menéndez Iglesias B. and Adorini L. (1997) IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159: 1604-1612
86. Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pospisil M., Young H. A. et al. (1991) Induction of interferon (production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869-879
87. Frei K., Siepl P., Groscurth P., Bodmer S., Schwerdel C. and Fontana A. (1987) Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17: 1271-1278
88. Trinchieri G. (1995) Interleukin 12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13: 251-276
89. Aloisi F., Ria F., Penna G. and Adorini L. (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol 160: 4671-4680
90. 2 secretion by microglia during antigen presentation to Th1 cells. J. Immunol. 162: 1384-1391
91. Van der Pouw Kraan T. C. T. M., Boeije L. C. M., Smeenk R. J. T., Wijdenes J. and Aarden L. A. (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181: 775-779
92. Wu C. Y., Wang K., McDyer J. F. and Seder R. A. (1998) Prostaglandin E2 and dexamethazone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161: 2723-2729
93. Kubin M., Kamoun M. and Trinchieri G. (1994) Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180: 211-222
94. Rott O., Fleisher B. and Cash F. (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24: 1434-1440
95. Issazadeh S., Ljungdahl A., Hoejeberg B., Mustafa M. and Olsson T. (1995) Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, tumor necrosis factor α and tumor necrosis factor β. J. Neuroimmunol. 61: 205-212
96. Segal B. M., Dwyer B. K. and Shevach E. M. (1998) An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187: 537-546
97. Hart M. N. and Fabry Z. (1995) CNS antigen presentation. Trends Neurosci. 18: 475-481
98. Powrie F. and Coffmann R. L. (1993) Cytokine regulation of T cell function: potential for therapeutic intervention. Immunol. Today 14: 270-274
99. O'Garra A. and Murphy K. (1993) T-cell subsets in autoimmunity. Curr. Opin. Immunol. 5: 880-886
100. 4 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34-38
101. Ando D. G., Clayton J., Kong D., Urban J. L. and Sercarz E. E. (1989) Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th1 lymphokine subtype. Cell. Immunol. 124: 132-143
102. 4 islet specific T cell clone. Science 249: 1433-1436
103. Bergman B. and Haskins K. (1994) Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 43: 197-203
104. Katz J. D., Benoist C. and Mathis D. (1995) T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188
105. Yang X.-D., Tisch R., Singer S. M., Cao Z. A., Liblau R. S., Schreiber R. D. et al. (1994) Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180: 995-1004
106. Wogesen L., Lee M.-S. and Sarvetnick N. (1994) Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179: 1379-1384
107. Anderson J. T., Cornelius J. G., Jarpe A. J., Winter W. E. and Peek A. B. (1993) Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event. Autoimmunity 15: 113-122
108. 4 islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182: 87-97
109. Veen R. C. van der and Stohlman S. A. (1993) Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48: 213-220
110. Khoury S. J., Hancock W. W. and Weiner H. L. (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176: 1355-1364
111. Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H. et al. (1993) Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178: 87-99
112. Pennline K. J., Roquegaffney H. and Monahan M. (1994) Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71: 169-175
113. 4 T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123: 37-64
114. 4 T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177: 627-636
115. Scott B., Liblau R., Degermann S., Marconi L. A., Ogata L., Caton A. J. et al. (1994) A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1: 1-20
116. Mueller R., Krahl T. and Sarvetnick N. (1996) Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184: 1093-1099
117. 4 Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95: 2979-2985
118. Moritani M., Yoshimoto K., Tashiro F., Hashimoto C., Miyazaki J., Ii S. et al. (1994) Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6: 1927-1936
119. De Carli M., D'Elios M., Mariotti S., Marcocci C., Pinchera A., Ricci M. et al. (1993) Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 77: 1120-1124
120. Brod S. A., Benjamin D. and Hafler D. A. (1991) Restricted T cell expression of IL-2, IFN-γ mRNA in human inflammatory disease. J. Immunol. 147: 810-815
121. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M. N., Cuzner M. L. et al. (1995) Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182: 1985-1996
122. 4 T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 94: 599-603
123. Comabella M., Balashov K., Issazadeh S., Smith D., Weiner H. L. and Khoury S. J. (1998) Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J. Clin. Invest. 102: 671-678
124. Foulis A. K., McGill M. and Farquahrson M. A. (1991) Insulitis in type I (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes and interferon-γ-containing cells. J. Pathol. 165: 97-103
125. Miltenburg A. M., Laar J. M. van, Kuiper R. de, Daha M. R. and Breedveld F. C. (1992) T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand. J. Immunol. 35: 603-610
126. De Carli M., D'Elios M. M., Zancuoghi G., Romagnani S. and Del Prete G. (1994) Human TH1 and TH2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 18: 301-308
127. Simon A. K., Seipelt E. and Sieper J. (1994) Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl Acad. Sci. USA 91: 8562-8566
128. Magram J., Connaughton S., Warrier R., Carvajal D., Wu C., Ferrante J. et al. (1996) IL-12 deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4: 471-482
129. Wu C-y., Ferrante J., Gately M. K. and Magram J. (1997) Characterization of IL-12 receptor β1 chain (IL-12R β1)-deficient mice: IL-12Rβ1 is an essential component of the functional mouse IL-12R. J. Immunol. 159: 1658-1665
130. Kaplan M. H., Sun Y.-L., Hoey T. and Grusby M. J. (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382: 174-177
131. Manner F., Magram J., Ferrante J., Launois P., Di Padova K., Behin R. et al. (1996) Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 response. Eur. J. Immunol. 26: 1553-1559
132. Cooper A. M., Magram J., Ferrante J. and Orme I. M. (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186: 39-45
133. Ottenhoff T. H. M., Kumararatne D. and Casanova J.-L. (1998) Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol. Today 19: 491-494
134. Schijns V. E. C. J., Haagmans B. L., Wierda C. M. H., Kruithof B., Heijnen I. A. F. M., Alber G. et al. (1998) Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 160: 3958-3964
135. Jong R. de, Altare F., Haagen I.-A., Elferink D. G., Boer T. de, Breda Vriesman P. J. C. van et al. (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280: 1435-1438
136. Seder R. A., Kelsall B. L. and Jankovic D. (1996) Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol. 157: 2745-2748
137. Adorini L., Aloisi F., Galbiati F., Gately M. K., Gregori S., Penna G. et al. (1997) Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases. Chem. Immunol. 68: 175-197
138. Trembleau S., Penna G., Gregori S., Gately M. K. and Adorini L. (1997) Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 27: 2230-2239
139. 2. Diabetologia 40: 641-646
140. Santambrogio L., Crisi G. M., Leu J., Hochwald G. M., Ryan T. and Thorbecke G. J. (1995) Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. J. Neuroimmunol. 58: 211-222
141. Chang J., Shevach E. and Segal B. (1999) Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J. Exp. Med. 189: 969-978
142. Germann T., Szeliga J., Hess H., Stoerkel S., Podlaski F. J., Gately M. K. et al. (1995) Administration of IL-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92: 4823-4827
143. McIntyre K. W., Shuster D. J., Gillooly K. M., Warrier R. R., Connaughton S. E., Hall R. B. et al. (1996) Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26: 2933-2938
144. Hess H., Gately M. K., Ruede E., Schmitt E., Szeliga J. and Germann T. (1996) High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur. J. Immunol. 26: 187-191
145. Stuber E., Strober W. and Neurath M. (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183: 693-698
146. Neurath M. F., Fuss I., Kelsall B. L., Presky D. H., Waegell W. and Strober W. (1996) Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183: 2605-2616
147. Rothe H., Jenkins N. A., Copeland N. G. and Kolb H. (1997) Active stage of autoimmune diabetes is associated with the expression of a novel cytokine. IGIF, which is located near Idd2. J. Clin. Invest. 99: 469-474
148. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T. et al. (1998) Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390
149. 4 cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production. J. Immunol. 159: 97-106
150. KB. Immunity 7: 571-581
151. Campbell I. L., Kay T. W., Oxbrow L. and Harrison L. C. (1991) Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87: 739-742
152. Debray-Sachs M., Carnaud C., Boitard C., Cohen H., Gresser I., Bedossa P. et al. (1991) Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J. Autoimmun. 4: 237-248
153. Hultgren B., Huang X., Dybdal N. and Stewart T. A. (1996) Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45: 812-817
154. Wang B., André L. Gonzales A., Katz J. D., Aguet M. and Benoist C. (1997) Interferon-γ impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94: 13844-13849
155. Herrath M. G. von and Oldstone M. B. A. (1997) Interferon-γ is essential for destruction of cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185: 531-540
156. Lu B., Ebensperger C., Dembic Z., Wang Y., Kvatyuk M., Lu T. et al. (1998) Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc. Natl. Acad. Sci USA 95: 8233-8238
157. Moiola L., Galbiati F., Martino G., Amadio S., Brambilla E., Comi G. et al. (1998) IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur. J. Immunol. 28: 2487-2497
158. Tarrant T K., Silver P. B., Chan C.-C., Wiggert B. and Caspi R. R. (1998) Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol. 161: 122-127
159. Bettelli E., Prabhu Das M., Howard E. D., Weiner H. L., Sobel R. A. and Kuchroo V. K. (1998) IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306
160. 4 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742
161. Lehuen A., Lantz O., Beaudoin L., Laloux V., Carnaud C., Bendelac A. et al. (1998) Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188: 1-9
162. Zheng X. X., Steele A. W., Hancock W. W., Stevens A. C., Nickerson P. W., Chaudhury P. R. et al. (1997) A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol. 158: 4507-4513
163. 4 T and B lymphocytes. J. Immunol. 161: 4420-4427
164. Steinman L. (1997) Some misconception about understanding autoimmunity through experiments with knockouts. J. Exp. Med. 185: 2039-2041
165. Balasa B., Deng C., Lee J., Bradley L. M., Dalton D. K., Christadoss P. et al. (1997) Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med. 186: 385-391
166. Gu D., Wogesen L., Calcutt N. A., Xia C., Zhu S., Merlie J. P. et al. (1995) Myasthenia gravis-like syndrome induced by expression of IFN-γ in the neuromuscolar junction. J. Exp. Med. 181: 547-557
167. Germann T., Bongartz M., Dlugonska H., Hess H., Schmitt E., Kolbe L. et al. (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25: 823-829
168. Vincent A. (1994) In: Cohen I. (ed.). pp. 83-106. Autoimmune Disease Models: A Guidebook, Experimental Autoimmune Myasthenia Gravis, Academic Press, New York
169. Jermy A., Beeson D. and Vincent A. (1993) Pathogenic autoimmunity to affinity purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Eur. J. Immunol. 23: 973-976